Oliver Grundmann, Ph.D.
Assistant Dean For Lifelong Learning And Clinical Professor
Department:
Entrepreneurial Programs in Medicinal Chemistry
Business Phone:
(352) 273-8691
Business Email:
grundman@ufl.edu
About Oliver Grundmann
Oliver Grundmann, Ph.D., received a bachelor’s degree in pharmacy and European pharmacist license from the University of Münster, Germany, in 2004 before beginning his graduate studies at the University of Florida. While continuing his Ph.D. in Pharmaceutical Sciences, he worked for the Forensic Science program after graduating with a master’s degree in Forensic Toxicology and minor in Statistics.
His research interests include the search for new treatment options from natural products for Central Nervous System and Gastrointestinal diseases such as anxiety and depressive disorders as well as irritable bowel syndrome and cancers of the gastrointestinal tract. Since 2016 a major collaborative research focus has been on Kratom (Mitragyna speciosa), its pharmacology and therapeutic potential as well as patterns of use.
He also is interested in the implementation and impact of national and international collaborations for curricular development in the health sciences with an emphasis on distance and online education.
Dr. Grundmann serves as the Director and faculty advisor for the online Master of Science and graduate certificate programs in Pharmaceutical Chemistry and Clinical Toxicology at the College of Pharmacy. In September 2023, he assumed the role of assistant dean of lifelong learning in the UF College of Pharmacy.
Related Links:
Accomplishments
President-Elect of the American College of Clinical Pharmacology
2022-2024
·
American College of Clinical Pharmacology
Faculty Advisor of the Year
2022
·
University of Florida College of Pharmacy
Faculty Diversity, Inclusion, and Health Equity (DIHE) Award
2022
·
University of Florida College of Pharmacy
Media Excellence Award
2022
·
University of Florida College of Pharmacy
Outstanding Teaching Team PharmD Year 2
2022
·
University of Florida College of Pharmacy
Outstanding Teaching Team PharmD Year 2
2021
·
University of Florida College of Pharmacy
Secretary of the American College of Clinical Pharmacology
2020-2022
·
American College of Clinical Pharmacology
Outstanding Teaching Team PharmD Year 1
2020
·
University of Florida College of Pharmacy
Outstanding Teaching Team PharmD Year 2, College of Pharmacy
2019
·
University of Florida
University of Florida Career Influencer Award
2019
·
University of Florida
Fellow of the American College of Clinical Pharmacology
2018
·
American College of Clinical Pharmacology
Outstanding Publication in Teaching Innovation or Clinical Practice Innovation, College of Pharmacy
2018
·
University of Florida
Outstanding Teaching Team PharmD Years 1, 2, & 3, College of Pharmacy
2018
·
University of Florida
American College of Clinical Pharmacology Excellence in Achievement recognition for STYP leadership
2017
·
American College of Clinical Pharmacology
Outstanding Teaching Team PharmD Year 2, College of Pharmacy
2017
·
University of Florida
Janet K. Poley Award for Innovation and Leadership in Distance Education
2015
·
American Distance Education Consortium
Poster Award, mentor of undergraduate students, UF College of Nursing Research day
2013
·
University of Florida
UF Open Access award for editorial services and the Journal of Alternative Medicine Studies
2012
·
University of Florida
Teaching Profile
Courses Taught
2018-2024
IDH2930 (Un)common read
2010-2012,2015-2024
PHA6936 Advanced Topics in Pharmaceutical Sciences
2010-2012,2015-2024
PHA6935 Selected Topics in Pharmacy
2015-2024
PHA6543 Pharmaceutical Chemistry II
2015-2024
PHA6556 Introduction to Clinical Toxicology
2015-2024
PHA6557 Clinical Toxicology 1
2010,2012-2015,2015-2024
PHA6354 Natural Medicinal Products
2010,2012-2015,2015-2024
PHA6417 Pharmaceutical Analysis II
2015-2024
PHA6432 Fundamentals of Pharmaceutical Chemistry
2011-2012,2015-2024
PHA6840 Medicinal Chemistry of Drugs of Abuse
2015-2024
PHA6357 Herbal & Dietary Supplements
2015-2024
PHA6444 Pharmaceutical Chemistry I
2016,2018-2019
PHA5782C Patient Care 2
2017-2019,2021-2024
PHA5787C Pt Care 5: Endo
2017-2019,2021-2024
PHA5784C Pt Care 4: GI and Renal
2018-2019,2021-2024
PHA5789C Patient Care 7
2017-2018
NGR7980 Research for Doctoral Dissertation
2016-2018,2021-2024
PHA5781 Patient Care I
2013-2017
PHA5352 Herbal Medicines
2017
PHA6471 Synthetic Medicinal Chemistry
2010-2012
PHA5437 Medicinal Chemistry 1
2010-2012
PHA5433 Funda Medicinal Chem
2010-2012
PHA5438 Medicinal Chemistry 2
2021
VME6934 Topics in Veterinary Medical Sciences
2021
PHA5787 Pharmacotherapy 5
2021
PHA5162L Prac Skills Lab II
2023-2024
PHA6532 Occupational Toxicology
2023-2024
PHA6533 Epidemiology & Biostatistics in Clinical Toxicology
2023-2024
PHA6539 Evidence-Based Applications in Clinical Toxicology
Research Profile
Open Researcher and Contributor ID (ORCID)
0000-0003-2302-8949
Publications
2024
An update on the clinical pharmacology of kratom: uses, abuse potential, and future considerations
Expert Review of Clinical Pharmacology.
17(2):131-142
[DOI] 10.1080/17512433.2024.2305798.
[PMID] 38217374.
2024
Commentary: Presence of kratom in opioid overdose deaths: findings from coroner postmortem toxicological report.
Frontiers in psychiatry.
15
[DOI] 10.3389/fpsyt.2024.1411964.
[PMID] 38846916.
2024
Ecological Momentary Assessment of Self-Reported Kratom Use, Effects, and Motivations Among US Adults.
JAMA network open.
7(1)
[DOI] 10.1001/jamanetworkopen.2023.53401.
[PMID] 38277146.
2024
Growing pains with kratom: experiences discussed in subreddits contrast with satisfaction expressed in surveys.
Frontiers in pharmacology.
15
[DOI] 10.3389/fphar.2024.1412397.
[PMID] 38948457.
2024
Kratom addiction per DSM-5 SUD criteria, and kratom physical dependence: Insights from dosing amount versus frequency.
Drug and alcohol dependence.
260
[DOI] 10.1016/j.drugalcdep.2024.111329.
[PMID] 38788532.
2024
Kratom as a potential substance use disorder harm reduction agent.
Frontiers in public health.
12
[DOI] 10.3389/fpubh.2024.1416689.
[PMID] 38873312.
2024
Kratom safety and toxicology in the public health context: research needs to better inform regulation.
Frontiers in pharmacology.
15
[DOI] 10.3389/fphar.2024.1403140.
[PMID] 38887550.
2024
Nalmefene Hydrochloride: Potential Implications for Treating Alcohol and Opioid Use Disorder
Substance Abuse and Rehabilitation.
Volume 15:43-57
[DOI] 10.2147/sar.s431270.
2024
Not all kratom is equal: The important distinction between native leaf and extract products
Addiction.
119(1):202-203
[DOI] 10.1111/add.16366.
2024
Novel methods for the remote investigation of emerging substances: Application to kratom.
Experimental and clinical psychopharmacology.
32(2):215-227
[DOI] 10.1037/pha0000656.
[PMID] 37213182.
2024
Prevalence of Kratom Use Disorder Among Kratom Consumers.
Journal of addiction medicine.
18(3):306-312
[DOI] 10.1097/ADM.0000000000001290.
[PMID] 38441236.
2024
Prevalence, Characteristics, and Reasons for Kratom Use among Psychiatrically Ill Inpatients Who Use Substances.
Journal of dual diagnosis.
20(2):87-97
[DOI] 10.1080/15504263.2023.2289456.
[PMID] 38153407.
2024
The Utilization and Development of Viral Vectors in Vaccines as a Prophylactic Treatment Against Ebola Virus as an Emerging and Zoonotic Infectious Disease
Mini-Reviews in Medicinal Chemistry.
24(3):289-299
[DOI] 10.2174/1389557523666230725115324.
2024
Use of Cannabinoids by People Who Consume Kratom in the United States.
Journal of addiction medicine.
[DOI] 10.1097/ADM.0000000000001346.
[PMID] 39012004.
2023
Addressing inequities in pharmaceutical education with an International Pharmaceutical Federation toolkit
Pharmacy Education.
23(1):560-573
[DOI] 10.46542/pe.2023.231.560573.
2023
Biomarkers and mechanisms associated with cancer‐induced cardiac cachexia: A systematic review
Journal of Cachexia, Sarcopenia and Muscle.
14(4):1900-1905
[DOI] 10.1002/jcsm.13267.
[PMID] 37211636.
2023
Correlations of kratom (Mitragyna speciosa Korth.) tea bag preparations and reported pharmacological effects
Journal of Ethnopharmacology.
317
[DOI] 10.1016/j.jep.2023.116779.
2023
Correlations of kratom (Mitragyna speciosa Korth.) use behavior and psychiatric conditions from a cross-sectional survey.
Experimental and Clinical Psychopharmacology.
31(5):963-977
[DOI] 10.1037/pha0000632.
[PMID] 36634016.
2023
Editorial: Education in ethnopharmacology 2022.
Frontiers in pharmacology.
14
[DOI] 10.3389/fphar.2023.1154280.
[PMID] 36843942.
2023
Evaluating health information provided to kratom consumers by good manufacturing practice-qualified vendors.
Substance abuse treatment, prevention, and policy.
18(1)
[DOI] 10.1186/s13011-023-00531-4.
[PMID] 37041624.
2023
Examining the paradoxical effects of kratom: a narrative inquiry.
Frontiers in pharmacology.
14
[DOI] 10.3389/fphar.2023.1174139.
[PMID] 37214465.
2023
Examining the Psychoactive Differences between Kratom Strains
International Journal of Environmental Research and Public Health.
20(14)
[DOI] 10.3390/ijerph20146425.
[PMID] 37510657.
2023
Kratom Alkaloids: A Blueprint?
ACS chemical neuroscience.
14(2):195-197
[DOI] 10.1021/acschemneuro.2c00704.
[PMID] 36594896.
2023
Kratom withdrawal: Discussions and conclusions of a scientific expert forum.
Drug and alcohol dependence reports.
7
[DOI] 10.1016/j.dadr.2023.100142.
[PMID] 37397437.
2023
Kratom: History, pharmacology, current user trends, adverse health effects and potential benefits.
Disease-a-month : DM.
69(6)
[DOI] 10.1016/j.disamonth.2022.101442.
[PMID] 35732553.
2023
Relevance of Dietary Supplement Use in Gastrointestinal-Cancer-Associated Cachexia
Nutrients.
15(15)
[DOI] 10.3390/nu15153391.
[PMID] 37571328.
2023
Subclinical Vitamin C Plasma Levels Associated with Increased Risk of CAD Diagnosis via Inflammation: Results from the NHANES 2003–2006 Surveys
Nutrients.
15(3)
[DOI] 10.3390/nu15030584.
[PMID] 36771290.
2023
Taking Action Towards Equity, Diversity, and Inclusion in the Pharmacy Curriculum and Continuing Professional Development.
American journal of pharmaceutical education.
87(2)
[DOI] 10.5688/ajpe8902.
[PMID] 35470170.
2022
A Novel Measure of Pain Location in Adults with Sickle Cell Disease
Pain Management Nursing.
23(6):693-702
[DOI] 10.1016/j.pmn.2022.09.004.
[PMID] 36261305.
2022
Acute, Sublethal, and Developmental Toxicity of Kratom (Mitragyna speciosa Korth.) Leaf Preparations on Caenorhabditis elegans as an Invertebrate Model for Human Exposure
International Journal of Environmental Research and Public Health.
19(10)
[DOI] 10.3390/ijerph19106294.
[PMID] 35627831.
2022
Drug‐Drug Interactions of Artemisinin‐Based Combination Therapies in Malaria Treatment: A Narrative Review of the Literature
The Journal of Clinical Pharmacology.
62(10):1197-1205
[DOI] 10.1002/jcph.2073.
2022
Editorial: The Pharmacology of Kratom and Its Alkaloids.
Frontiers in pharmacology.
13
[DOI] 10.3389/fphar.2022.878376.
[PMID] 35370662.
2022
Exploring the self-reported motivations of kratom (Mitragyna speciosa Korth.) use: a cross-sectional investigation
The American Journal of Drug and Alcohol Abuse.
48(4):433-444
[DOI] 10.1080/00952990.2022.2041026.
2022
Front‐Line Health Care Professionals Lack Critical Knowledge in Dietary Supplement and Nutraceutical Products: A Call to Action for Comprehensive Educational Opportunities
The Journal of Clinical Pharmacology.
62(1):17-19
[DOI] 10.1002/jcph.1985.
2022
How Essential is Kratom Availability and use during COVID-19? Use Pattern Analysis Based on Survey and Social Media Data
Substance Abuse.
43(1):865-877
[DOI] 10.1080/08897077.2021.2007517.
[PMID] 35179453.
2022
Kratom as an opioid alternative: harm, or harm reduction? A systematic review of literature
The American Journal of Drug and Alcohol Abuse.
48(5):509-528
[DOI] 10.1080/00952990.2022.2111685.
2022
Kratom use as more than a “self-treatment”
The American Journal of Drug and Alcohol Abuse.
48(6):684-694
[DOI] 10.1080/00952990.2022.2083967.
[PMID] 35767669.
2022
Need for Clarity and Context in Case Reports on Kratom Use, Assessment, and Intervention
Substance Abuse.
43(1):1221-1224
[DOI] 10.1080/08897077.2022.2074608.
2022
Regulation of Dietary Supplements and Nutraceutical Products in the United States: An Argument for Greater Oversight and Uniform Standards
The Journal of Clinical Pharmacology.
62(1):14-16
[DOI] 10.1002/jcph.1982.
2022
Searching for a Signal: Self-Reported Kratom Dose-Effect Relationships Among a Sample of US Adults With Regular Kratom Use Histories.
Frontiers in pharmacology.
13
[DOI] 10.3389/fphar.2022.765917.
[PMID] 35300296.
2022
Social, psychological, and substance use characteristics of U.S. adults who use kratom: Initial findings from an online, crowdsourced study.
Experimental and Clinical Psychopharmacology.
30(6):983-996
[DOI] 10.1037/pha0000518.
[PMID] 34735202.
2022
The Importance of Diversity and Inclusion in Drug Development and Clinical Trial Conduct
The Journal of Clinical Pharmacology.
62(12):1475-1479
[DOI] 10.1002/jcph.2151.
2022
The Use of Kratom (Mitragyna speciosa Korth.) Among People Who Co-use Heroin and Methamphetamine in Malaysia.
Journal of addiction medicine.
16(2):223-228
[DOI] 10.1097/ADM.0000000000000876.
[PMID] 34001777.
2022
Understanding Kratom Use: A Guide for Healthcare Providers.
Frontiers in pharmacology.
13
[DOI] 10.3389/fphar.2022.801855.
[PMID] 35308216.
2022
Vitamin C Plasma Levels Associated with Inflammatory Biomarkers, CRP and RDW: Results from the NHANES 2003–2006 Surveys
Nutrients.
14(6)
[DOI] 10.3390/nu14061254.
[PMID] 35334908.
2022
We Need Better Estimates of Kratom Use Prevalence
American Journal of Preventive Medicine.
62(1):132-133
[DOI] 10.1016/j.amepre.2021.07.022.
2022
“Misstatements in Artemisinin‐Based Combination Therapies in Malaria Treatment” by Fleckenstein and Miller
The Journal of Clinical Pharmacology.
62(10):1323-1324
[DOI] 10.1002/jcph.2115.
2021
Clinical Pharmacology, Toxicity, and Abuse Potential of Opioids
The Journal of Clinical Pharmacology.
61(S2)
[DOI] 10.1002/jcph.1923.
2021
Glycyrrhizin as a Potential Treatment for the Novel Coronavirus (COVID-19)
Mini-Reviews in Medicinal Chemistry.
21(16):2204-2208
[DOI] 10.2174/1389557521666210210160237.
2021
Insufficient Vitamin C Levels among Adults in the United States: Results from the NHANES Surveys, 2003–2006
Nutrients.
13(11)
[DOI] 10.3390/nu13113910.
[PMID] 34836166.
2021
Is kratom (Mitragyna speciosa Korth.) use associated with ECG abnormalities? Electrocardiogram comparisons between regular kratom users and controls.
Clinical toxicology (Philadelphia, Pa.).
59(5):400-408
[DOI] 10.1080/15563650.2020.1812627.
[PMID] 32870119.
2021
Kratom use in the United States: a diverse and complex profile
Addiction.
116(1):202-203
[DOI] 10.1111/add.15173.
[PMID] 32602213.
2021
Kratom Use Within the Context of the Evolving Opioid Crisis and the COVID-19 Pandemic in the United States.
Frontiers in pharmacology.
12
[DOI] 10.3389/fphar.2021.729220.
[PMID] 34512353.
2021
Therapeutic benefit with caveats?: Analyzing social media data to understand the complexities of kratom use
Drug and Alcohol Dependence.
226
[DOI] 10.1016/j.drugalcdep.2021.108879.
[PMID] 34216869.
2020
Can Kratom (Mitragyna speciosa) Alleviate COVID-19 Pain? A Case Study.
Frontiers in psychiatry.
11
[DOI] 10.3389/fpsyt.2020.594816.
[PMID] 33329145.
2020
Current and Future Potential Impact of COVID-19 on Kratom (Mitragyna speciosa Korth.) Supply and Use.
Frontiers in psychiatry.
11
[DOI] 10.3389/fpsyt.2020.574483.
[PMID] 33324252.
2020
Differential response to targeted acupuncture by gender in patients with gastrointestinal cancer cachexia: secondary analysis of a randomized controlled trial
Acupuncture in Medicine.
38(1):53-60
[DOI] 10.1177/0964528419873670.
[PMID] 31544469.
2020
Evaluation of the Mitragynine Content, Levels of Toxic Metals and the Presence of Microbes in Kratom Products Purchased in the Western Suburbs of Chicago
International Journal of Environmental Research and Public Health.
17(15)
[DOI] 10.3390/ijerph17155512.
[PMID] 32751712.
2020
Public Perceptions toward Kratom (Mitragyna Speciosa) Use in Malaysia
Journal of Psychoactive Drugs.
52(3):282-288
[DOI] 10.1080/02791072.2020.1738603.
2020
Self-Report Data on Regular Consumption of Illicit Drugs and HIV Risk Behaviors after Kratom (Mitragyna Speciosa korth.) Initiation among Illicit Drug Users in Malaysia
Journal of Psychoactive Drugs.
52(2):138-144
[DOI] 10.1080/02791072.2019.1686553.
2020
Self-reported Health Diagnoses and Demographic Correlates With Kratom Use: Results From an Online Survey.
Journal of addiction medicine.
14(3):244-252
[DOI] 10.1097/ADM.0000000000000570.
[PMID] 31567595.
2020
The Burden of the Serious and Difficult-to-Treat Infections and a New Antibiotic Available: Cefiderocol.
Frontiers in pharmacology.
11
[DOI] 10.3389/fphar.2020.578823.
[PMID] 33628170.
2020
The Pharmacist as an LGBTQ Ally.
American journal of pharmaceutical education.
84(7)
[DOI] 10.5688/ajpe7835.
[PMID] 32773835.
2020
The Potential for Kratom as an Antidepressant and Antipsychotic.
The Yale journal of biology and medicine.
93(2):283-289
[PMID] 32607089.
2020
The Use of Benzodiazepines among Kratom ( Mitragyna Speciosa Korth.) Users
Journal of Psychoactive Drugs.
52(1):86-92
[DOI] 10.1080/02791072.2019.1632505.
2019
<p>Current perspectives on the impact of Kratom use</p>
Substance Abuse and Rehabilitation.
Volume 10:23-31
[DOI] 10.2147/sar.s164261.
2019
Association of Kratom Use with Impairment: Many Legal Questions Remain
Journal of Analytical Toxicology.
43(5):e8-e9
[DOI] 10.1093/jat/bkz012.
2019
Augmentation of Cancer Cachexia Components With Targeted Acupuncture in Patients With Gastrointestinal Cancers: A Randomized Controlled Pilot Study
Integrative Cancer Therapies.
18
[DOI] 10.1177/1534735418823269.
[PMID] 30791747.
2019
Constipation prevalence and fatigue severity in regular kratom (Mitragyna speciosa Korth.) users
Journal of Substance Use.
24(3):233-239
[DOI] 10.1080/14659891.2018.1546340.
2019
Critique of “Kratom Use and Toxicities in the United States”
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.
39(11):1119-1120
[DOI] 10.1002/phar.2336.
2019
Current perspectives on the impact of Kratom use
Substance Abuse and Rehabilitation.
Volume 10:23-31
[DOI] 10.2147/sar.s164261.
2019
Dietary Supplement and Complementary and Alternative Medicine Use Are Highly Prevalent in Patients with Gastrointestinal Disorders: Results from an Online Survey
Journal of Dietary Supplements.
16(6):635-648
[DOI] 10.1080/19390211.2018.1472712.
2019
Distinct kratom user populations across the United States: A regional analysis based on an online survey
Human Psychopharmacology: Clinical and Experimental.
34(5)
[DOI] 10.1002/hup.2709.
2019
Effects of Kratom (Mitragyna Speciosa Korth.) Use in Regular Users
Substance Use & Misuse.
54(14):2284-2289
[DOI] 10.1080/10826084.2019.1645178.
2019
Kratom policy: The challenge of balancing therapeutic potential with public safety
International Journal of Drug Policy.
70:70-77
[DOI] 10.1016/j.drugpo.2019.05.003.
[PMID] 31103778.
2019
Non-Prescribed Buprenorphine Use Mediates the Relationship between Heroin Use and Kratom Use among a Sample of Polysubstance Users
Journal of Psychoactive Drugs.
51(4):311-322
[DOI] 10.1080/02791072.2019.1597224.
[PMID] 30961450.
2019
Risk of death associated with kratom use compared to opioids
Preventive Medicine.
128
[DOI] 10.1016/j.ypmed.2019.105851.
2019
Self-reported prevalence and severity of opioid and kratom (Mitragyna speciosa korth.) side effects.
Journal of ethnopharmacology.
238
[DOI] 10.1016/j.jep.2019.111876.
[PMID] 31014959.
2018
Assessment of gonadotropins and testosterone hormone levels in regular Mitragyna speciosa (Korth.) users
Journal of Ethnopharmacology.
221:30-36
[DOI] 10.1016/j.jep.2018.04.005.
2018
Body composition changes differ by gender in stomach, colorectal, and biliary cancer patients with cachexia: Results from a pilot study
Cancer Medicine.
7(8):3695-3703
[DOI] 10.1002/cam4.1665.
[PMID] 29971962.
2018
Gastrointestinal symptom improvement from fiber, STW 5, peppermint oil, and probiotics use—Results from an online survey
Complementary Therapies in Medicine.
41:225-230
[DOI] 10.1016/j.ctim.2018.10.003.
2018
Pregnancy and herbal medicines: An unnecessary risk for women’s health—A narrative review
Phytotherapy Research.
32(5):796-810
[DOI] 10.1002/ptr.6020.
2018
The development and impact of active learning strategies on self-confidence in a newly designed first-year self-care pharmacy course – outcomes and experiences.
Currents in pharmacy teaching & learning.
10(4):499-504
[DOI] 10.1016/j.cptl.2017.12.008.
[PMID] 29793713.
2018
The medicinal chemistry and neuropharmacology of kratom: A preliminary discussion of a promising medicinal plant and analysis of its potential for abuse
Neuropharmacology.
134:108-120
[DOI] 10.1016/j.neuropharm.2017.08.026.
2018
The therapeutic potential of kratom
Addiction.
113(10):1951-1953
[DOI] 10.1111/add.14371.
2017
Evaluating the knowledge base and current training of paramedics in the southwest United States in assessing and managing toxic alcohol exposures
Australasian Journal of Paramedicine.
14(2)
[DOI] 10.33151/ajp.14.2.522.
2017
In vitro assays in natural products research – a matter of concentration and relevance to in vivo administration using resveratrol, α-mangostin/γ-mangostin and xanthohumol as examples.
Natural product research.
31(5):492-506
[DOI] 10.1080/14786419.2016.1190721.
[PMID] 27234135.
2017
Patterns of Kratom use and health impact in the US—Results from an online survey
Drug and Alcohol Dependence.
176:63-70
[DOI] 10.1016/j.drugalcdep.2017.03.007.
2017
Preclinical and Potential Applications of Common Western Herbal Supplements as Complementary Treatment in Parkinson’s Disease.
Journal of dietary supplements.
14(4):453-466
[DOI] 10.1080/19390211.2016.1263710.
[PMID] 28095073.
2016
Review of Various Herbal Supplements as Complementary Treatments for Oral Cancer.
Journal of dietary supplements.
13(5):538-50
[DOI] 10.3109/19390211.2015.1122693.
[PMID] 26863913.
2016
The pharmacology and toxicology of kratom: from traditional herb to drug of abuse.
International journal of legal medicine.
130(1):127-38
[DOI] 10.1007/s00414-015-1279-y.
[PMID] 26511390.
2015
A brief review of krill oil history, research, and the commercial market.
Journal of dietary supplements.
12(1):23-35
[DOI] 10.3109/19390211.2014.902000.
[PMID] 24689485.
2015
Influence of acupuncture on bioelectrical impedance measures in patients with gastrointestinal cancer: results of a pilot study.
Acupuncture in medicine : journal of the British Medical Acupuncture Society.
33(1):16-22
[DOI] 10.1136/acupmed-2014-010667.
[PMID] 25413610.
2015
Mitochondriotropic nanoemulsified genistein-loaded vehicles for cancer therapy.
Methods in molecular biology (Clifton, N.J.).
1265:85-101
[DOI] 10.1007/978-1-4939-2288-8_7.
[PMID] 25634269.
2015
Novel intervention with acupuncture for anorexia and cachexia in patients with gastrointestinal tract cancers: a feasibility study.
Oncology nursing forum.
42(2):E102-9
[DOI] 10.1188/15.ONF.E102-E109.
[PMID] 25806891.
2015
The Physicochemical and Pharmacokinetic Relationships of Barbiturates – From the Past to the Future.
Current pharmaceutical design.
21(25):3681-91
[PMID] 25824249.
2015
The value of bioelectrical impedance analysis and phase angle in the evaluation of malnutrition and quality of life in cancer patients—a comprehensive review
European Journal of Clinical Nutrition.
69(12):1290-1297
[DOI] 10.1038/ejcn.2015.126.
2014
Complementary and alternative medicines in irritable bowel syndrome: an integrative view.
World journal of gastroenterology.
20(2):346-62
[DOI] 10.3748/wjg.v20.i2.346.
[PMID] 24574705.
2014
The current state of bioterrorist attack surveillance and preparedness in the US.
Risk management and healthcare policy.
7:177-87
[DOI] 10.2147/RMHP.S56047.
[PMID] 25328421.
2013
Factors that influence the variability in findings of anogenital injury in adolescent/adult sexual assault victims: a review of the forensic literature.
The American journal of forensic medicine and pathology.
34(3):286-94
[DOI] 10.1097/PAF.0b013e31829a0f46.
[PMID] 23835534.
2013
Menthol–pharmacology of an important naturally medicinal “cool”.
Mini reviews in medicinal chemistry.
13(1):124-31
[PMID] 23061635.
2013
Mind-Body Therapies for Functional Bowel Disorders-a Review of Recent Clinical Trials
European Journal of Integrative Medicine.
5(4):296-307
[DOI] 10.1016/j.eujim.2013.03.007.
2012
An orthomolecular approach to the prevention and treatment of psychiatric disorders.
Advances in mind-body medicine.
26(2):14-28
[PMID] 23341413.
2012
Clinical evaluation of liquid placebos for an herbal supplement, STW5, in healthy volunteers.
Complementary therapies in medicine.
20(5):267-74
[DOI] 10.1016/j.ctim.2012.04.003.
[PMID] 22863640.
2011
Management of irritable bowel syndrome (IBS) in adults: conventional and complementary/alternative approaches.
Alternative medicine review : a journal of clinical therapeutic.
16(2):134-51
[PMID] 21649455.
2011
The use of glucosamine, devil’s claw (Harpagophytum procumbens), and acupuncture as complementary and alternative treatments for osteoarthritis.
Alternative medicine review : a journal of clinical therapeutic.
16(3):228-38
[PMID] 21951024.
2010
Current developments for the diagnosis and treatment of irritable bowel syndrome.
Current pharmaceutical design.
16(33):3638-45
[PMID] 21128902.
2010
Insulin-like growth factor-1 preserves salivary gland function after fractionated radiation.
International journal of radiation oncology, biology, physics.
78(2):579-86
[DOI] 10.1016/j.ijrobp.2010.03.035.
[PMID] 20638195.
2010
Irritable bowel syndrome: epidemiology, diagnosis and treatment: an update for health-care practitioners.
Journal of gastroenterology and hepatology.
25(4):691-9
[DOI] 10.1111/j.1440-1746.2009.06120.x.
[PMID] 20074154.
2010
Mechanism of St. John’s wort extract (STW3-VI) during chronic restraint stress is mediated by the interrelationship of the immune, oxidative defense, and neuroendocrine system.
Neuropharmacology.
58(4-5):767-73
[DOI] 10.1016/j.neuropharm.2009.12.014.
[PMID] 20036263.
2009
Anxiolytic effects of a passion flower (Passiflora incarnata L.) extract in the elevated plus maze in mice.
Die Pharmazie.
64(1):63-4
[PMID] 19216234.
2009
Kaempferol from the leaves of Apocynum venetum possesses anxiolytic activities in the elevated plus maze test in mice.
Phytomedicine : international journal of phytotherapy and phytopharmacology.
16(4):295-302
[DOI] 10.1016/j.phymed.2008.12.020.
[PMID] 19303276.
2009
Radiation-induced salivary gland dysfunction results from p53-dependent apoptosis.
International journal of radiation oncology, biology, physics.
73(2):523-9
[DOI] 10.1016/j.ijrobp.2008.09.036.
[PMID] 19147016.
2008
Antistress Effects of St. John’S Wort in a Pharmacological Model
Naunyn-Schmiedebergs Archives of Pharmacology.
377
2008
Anxiolytic activity of a phytochemically characterized Passiflora incarnata extract is mediated via the GABAergic system.
Planta medica.
74(15):1769-73
[DOI] 10.1055/s-0028-1088322.
[PMID] 19006051.
2008
Anxiolytic Activity of Apocynum Venetum L. and Its Proposed Mechanism of Action
Planta Medica.
74
2007
Anti-anxiety effects of Apocynum venetum L. in the elevated plus maze test.
Journal of ethnopharmacology.
110(3):406-11
[PMID] 17101250.
2007
Hypothermic effects of hops are antagonized with the competitive melatonin receptor antagonist luzindole in mice.
The Journal of pharmacy and pharmacology.
59(4):549-52
[PMID] 17430638.
2007
Salvia divinorum and salvinorin A: an update on pharmacology and analytical methodology.
Planta medica.
73(10):1039-46
[PMID] 17628834.
2006
Antidepressant effect of extracts from Ginkgo biloba leaves in behavioral models.
Biological & pharmaceutical bulletin.
29(8):1767-70
[PMID] 16880641.
2006
Effects of St. John’s wort extract and single constituents on stress-induced hyperthermia in mice.
Planta medica.
72(15):1366-71
[PMID] 17051457.
Education
M.Ed.
2014
·
University of Florida
M.S.
2007
·
University of Florida
Ph.D.
2007
·
University of Florida
Contact Details
Phones:
- Business:
- (352) 273-8691
Emails:
- Business:
- grundman@ufl.edu
Addresses:
- Business Mailing:
-
PO BOX 100485
Gainesville FL 32610 - Business Street:
-
Room P3-12
1345 Center Drive
Gainesville FL 32610